Cicenas, J., & Račienė, A. (2021). Anti-Cancer Drugs Targeting Protein Kinases Approved by FDA in 2020. Cancers (Basel).
Citación estilo ChicagoCicenas, Jonas, y Asta Račienė. "Anti-Cancer Drugs Targeting Protein Kinases Approved By FDA in 2020." Cancers (Basel) 2021.
Cita MLACicenas, Jonas, y Asta Račienė. "Anti-Cancer Drugs Targeting Protein Kinases Approved By FDA in 2020." Cancers (Basel) 2021.
Precaución: Estas citas no son 100% exactas.